7 completed. 7 Phase 4.
| Phase | Trials | Status |
|---|---|---|
| Phase 4 | 7 | Completed 7 |
Follow Hypothalamic Neoplasms: new trials by email Literature Review of Hypothalamic Neoplasms trials Research Report on Hypothalamic Neoplasms
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Comparison of Postoperative Recovery of Sevoflurane and Propofol After Transsphenoidal Surgery sevoflurane, propofol - Pituitary Adenoma | Phase 4 | Completed | Peking Union Medical College Hospital | 252 | 2023-05-03 | 2025-06-08 |
| The Effect of Local Anesthesia on Postopanalgesia in Patients Using Head Holder lidocaine was administered subcutaneously at 0.5% concentration., lidocaine was administered subcutaneously at 1% concentration. - Postoperative Pain, Acute | Phase 4 | Completed | Kocaeli University | 75 | 2018-01-10 | 2026-06-05 |
| Analgesia Regimens Following Trans-sphenoidal Surgery for Pituitary Tumors IV Caldolor, IV Placebo - Pituitary Tumor, Pain | Phase 4 | Completed | St. Joseph's Hospital and Medical Center, Phoenix | 62 | 2015-02-01 | 2021-10-21 |
| Study to Allow Access to Pasireotide for Patients Benefiting From Pasireotide Treatment in Novartis-sponsored Studies Pasireotide, Cabergoline, Pasireotide LAR - Cushing's Disease, Acromegaly | Phase 4 | Completed | RECORDATI GROUP | 337 | 2013-06-10 | 2024-10-01 |
| Efficacy of Octreotide Acetate and Cabergoline in Patients With Acromegaly Octreotide acetate and cabergoline/Octrotide and Somavert - Acromegaly | Phase 4 | Completed | Novartis Pharmaceuticals | 20 | 2006-03-01 | 2017-03-06 |
| Surgical Debulking of Pituitary Adenomas Octreotide LAR, transsphenoidal surgery - Pituitary Adenoma | Phase 4 | Completed | NYU Langone Health | 41 | 2004-04-01 | 2016-08-29 |
| Dose Escalation of Octreotide-LAR as First-Line Therapy in Resistant Acromegaly Octreotide-LAR - Acromegaly | Phase 4 | Completed | Federico II University | 50 | 1995-01-01 | 2007-04-17 |
Pituitary Neoplasms (7) · Acromegaly (3) · Brain Neoplasms (1) · Dumping Syndrome (1) · Melanoma (1) · Neoplasms (1) · Neuroendocrine Tumors (1) · Pain (1) · Pain, Postoperative (1) · Pituitary ACTH Hypersecretion (1) · Prostatic Neoplasms (1)
Brain Diseases (7) · Central Nervous System Diseases (7) · Central Nervous System Neoplasms (7) · Endocrine Gland Neoplasms (7) · Endocrine System Diseases (7) · Hypothalamic Diseases (7) · Neoplasms by Site (7) · Nervous System Diseases (7) · Nervous System Neoplasms (7) · Pituitary Diseases (7) · Supratentorial Neoplasms (7) · Brain Neoplasms (6) · Neoplasms (6) · Bone Diseases (3)
Cabergoline (2) · Ibuprofen (1) · Octreotide (1) · Propofol (1) · Sevoflurane (1) · pasireotide (1) · pegvisomant (1)
Federico II University (1) · Kocaeli University (1) · NYU Langone Health (1) · Novartis Pharmaceuticals (1) · Peking Union Medical College Hospital (1) · RECORDATI GROUP (1) · St. Joseph's Hospital and Medical Center, Phoenix (1)
United States (3) · Germany (2) · Italy (2) · Turkey (Türkiye) (2) · Argentina (1) · Belgium (1) · Brazil (1) · Bulgaria (1) · Canada (1) · China (1) · France (1) · Greece (1) · Hungary (1) · India (1) · Israel (1)
Andrew S Little, MD (1) · Annamaria AL Colao, Prof. (1) · Bing Xing, MD (1) · David M Kleinberg, MD (1) · Lulu Ma, MD (1) · Wei Lian, MD (1) · Yuguang Huang, MD (1)
PMID 10469005, PMID 10690849, PMID 10999798, PMID 11397887, PMID 12843148, PMID 14764779, PMID 15070920, PMID 15613435, PMID 15827109, PMID 15886238, PMID 15886256, PMID 16373932, PMID 16449332, PMID 16487447, PMID 16537687, PMID 17984237, PMID 28298041, PMID 3899825, PMID 40760415, PMID 5427331, PMID 8050136, PMID 8327647, PMID 8514973, PMID 9709939, PMID 9768640, PMID 9768641, PMID 9808008